The impact of intravenous ferric carboxymaltose on echocardiographic markers of cardiac function in patients with HFrEF and cardiac implantable electronic devices: sub-analysis of the RESAFE-HF trial
The effect of intravenous ferric carboxymaltose on the arrhythmic burden of HFrEF patients with cardiac implantable electronic devices: RESAFE-HF study preliminary results
The additive value of pre- and post-reperfusion cardiac troponin T levels in risk stratification of patients with ST-segment elevation myocardial infarction